BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29208006)

  • 1. Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.
    Wang Q; Gan H; Chen C; Sun Y; Chen J; Xu M; Weng W; Cao L; Xu Q; Wang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):176. PubMed ID: 29208006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.
    Spector Y; Fridman E; Rosenwald S; Zilber S; Huang Y; Barshack I; Zion O; Mitchell H; Sanden M; Meiri E
    Mol Oncol; 2013 Jun; 7(3):732-8. PubMed ID: 23587442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of human renal carcinomas with functional taxonomic analysis.
    Gieseg MA; Cody T; Man MZ; Madore SJ; Rubin MA; Kaldjian EP
    BMC Bioinformatics; 2002 Sep; 3():26. PubMed ID: 12356337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
    Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
    J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
    Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours.
    Yusenko MV; Zubakov D; Kovacs G
    Int J Biol Sci; 2009 Jul; 5(6):517-27. PubMed ID: 19680475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression identifies subgroups of renal cell carcinoma.
    Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
    J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.